Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

57.16
-0.4700-0.82%
Post-market: 57.160.00000.00%19:30 EDT
Volume:2.23M
Turnover:127.83M
Market Cap:32.98B
PE:30.66
High:57.91
Open:57.64
Low:56.96
Close:57.63
52wk High:64.38
52wk Low:35.23
Shares:576.94M
Float Shares:392.53M
Volume Ratio:0.82
T/O Rate:0.57%
Dividend:0.91
Dividend Rate:1.59%
EPS(TTM):1.86
EPS(LYR):1.78
ROE:13.97%
ROA:5.09%
PB:4.83
PE(LYR):32.09

Loading ...

Neurimmune: in Q1 of 2027, Royalty Pharma Will Provide Another $125 Mln in Cash to Co

THOMSON REUTERS
·
Jul 22

Neurimmune Sells a Portion of Its Royalty Interest in Cliramitug to Royalty Pharma

THOMSON REUTERS
·
Jul 22

Neurimmune: Sold Portion of Its Royalty Interest in Cliramitug to Royalty Pharma for up to $425 Mln

THOMSON REUTERS
·
Jul 22

Royalty Pharma Maintains Quarterly Dividend at $0.235 a Share, Payable on Sept. 10 to Shareholders of Record on Aug. 14

MT Newswires Live
·
Jul 18

Press Release: Royalty Pharma Declares Third Quarter 2026 Dividend

Dow Jones
·
Jul 18

Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 16

Royalty Pharma to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 16

Royalty Pharma to Announce Second Quarter 2026 Financial Results on August 5, 2026

THOMSON REUTERS
·
Jul 16

Royalty Pharma : TD Cowen Raises Target Price to $65 from $50

THOMSON REUTERS
·
Jul 13

Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX)

TIPRANKS
·
Jul 10

Royalty Pharma EVP Christopher Hite Sells USD 7.38 Million in Common Shares

Reuters
·
Jul 03

Royalty Pharma Forecasts Q2 Portfolio Receipts at $740 Million-$760 Million

Reuters
·
Jul 01

Royalty Pharma EVP, Chairman Partnering Christopher Hite Sells USD 8.15 Million in Common Shares

Reuters
·
Jun 26

Don't Ignore The Insider Selling In Royalty Pharma

Simply Wall St.
·
Jun 18

Royalty Pharma to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
Jun 05

Royalty Pharma shareholders elect nine directors at annual meeting

Reuters
·
Jun 05

Royalty Pharma CFO Terrance P. Coyne disposes of 64,399 shares worth $3.48 million

Reuters
·
May 29

BRIEF-Royalty Pharma - Enters Revolving Credit Agreement On May 22, 2026

Reuters
·
May 29

Royalty Pharma - Revolving Credit Facility to Mature on May 22, 2031 - SEC Filing

THOMSON REUTERS
·
May 29

Royalty Pharma - Credit Agreement Provides for $1.8 Bln Unsecured Revolving Credit Facility - SEC Filing

THOMSON REUTERS
·
May 29